Immunity beyond cancer cells: Perspective from tumor tissue Review


Authors: Gao, S.; Hsu, T. W.; Li, M. O.
Review Title: Immunity beyond cancer cells: Perspective from tumor tissue
Abstract: Investigation of cancer as a cell-level disease has led to the development of cancer cell-directed therapies including cytotoxic T lymphocyte (CTL)-based immunotherapy; yet, many patients are refractory to these modalities of cancer treatment and acquired resistance frequently occurs. Of note, cancer environment controls the manifestation of cancerous cell phenotype. Helper T (Th) cells orchestrate immune defense responses targeting cancer cells as well as the tumor microenvironment. Recent studies have shown that in addition to interferon (IFN)-gamma-producing Th1 cells, interleukin (IL)-4-producing Th2 cells function as potent anticancer effectors in part by promoting tumor stroma reconfiguration and tumor tissue repair. Such Th cell-mediated tissue-level immunity may be harnessed for novel modalities of cancer environment immunotherapy.
Keywords: immunotherapy; microenvironment; differentiation; prostate-cancer; cells; t-cell; acquired-resistance; th2; promotes; dependent mechanism; il-17
Journal Title: Trends in Cancer
Volume: 7
Issue: 11
ISSN: 2405-8025
Publisher: Cell Press  
Date Published: 2021-11-01
Start Page: 1010
End Page: 1019
Language: English
ACCESSION: WOS:000709306500006
DOI: 10.1016/j.trecan.2021.06.007
PROVIDER: wos
PMCID: PMC8541902
PUBMED: 34305041
Notes: Review -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ming Li
    111 Li
  2. Shengyu Gao
    4 Gao
  3. Ting-Wei Hsu
    3 Hsu